Treatment of sleep apnea via bilateral stimulation

What is this patent about?

’318 is related to the field of implantable neuromodulation devices and, more specifically, to systems designed for the bilateral stimulation of the hypoglossal nerves to treat sleep-related breathing disorders such as obstructive sleep apnea. The technology addresses the need for effective, minimally invasive solutions that can maintain airway patency by inducing controlled contractions of the genioglossus muscle through precise electrical targeting of the nerves responsible for tongue movement.

The underlying idea behind ’318 is the use of a single, multi-armed implantable carrier that straddles the tongue anatomy to provide bilateral stimulation without requiring direct nerve contact. By utilizing a specific geometry where electrodes are placed on elongated arms extending from a central hub, the device can generate electric fields that penetrate muscle tissue to reach the medial branches of both the left and right hypoglossal nerves. The core innovation lies in the delivery of a coordinated, alternating stimulation sequence that employs polarity reversals to mitigate neuronal fatigue and prevent long-term tissue damage while ensuring symmetric airway dilation.

The claims of ’318 focus on a carrier structure featuring a central portion with two extending arms, each supporting a dedicated pair of modulation electrodes. These electrodes are specifically configured to facilitate independent electric fields on opposite sides of the subject’s midline. The independent claims further define a control unit and processing logic that manages the wireless transmission of signals to these electrodes, specifically requiring a sequence that alternates the polarity of the electric fields between the first and second pairs of electrodes to achieve bilateral neuromodulation.

In practice, the device is implanted under the chin, positioning the central hub near the geniohyoid muscle while the arms wrap toward the horizontal compartment of the genioglossus. An external unit, typically a skin patch, transmits power and control logic via inductive coupling to a secondary antenna on the implant. This wireless link allows the processor to dynamically adjust the stimulation pulse train based on the degree of coupling, which serves as a proxy for tongue position and movement. By monitoring these feedback signals, the system can detect the onset of an apnea event and trigger the necessary muscular contraction to clear the airway.

This approach differs from prior solutions by moving away from cuff-based electrodes that require surgical wrapping of the nerve trunk, which can lead to scarring or loss of efficacy if the lead migrates. Instead, the ’318 design utilizes parallel electric field lines that allow for contactless modulation, making the system more resilient to the natural movement of the tongue and the development of fibrous tissue. Furthermore, the specific focus on alternating bilateral stimulation provides a more balanced physiological response than unilateral systems, reducing the likelihood of asymmetrical tongue protrusion and improving overall patient comfort during sleep.